LAMEA Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 - 2028

The Latin America, Middle East and Africa Analgesics Market would witness market growth of 8.8% CAGR during the forecast period (2022-2028).

Analgesics have observed a large increase in the demand over the years due to the rising therapeutic benefits they provide, as well as effective and quick pain relief. The analgesics market has also benefited from the introduction of novel medications and increased knowledge of these treatment options. Furthermore, a surge in the incidence of recurring aches and pains as a result of a rise in the frequency of cancer, arthritis, cardiovascular disease, and other chronic and acute disorders has boosted analgesic demand. The rising prevalence of pain worldwide, the growth in effective treatment choices, and the growing adoption of analgesics by a wider target audience are all factors that are positively impacting the analgesics market.

The United Arab Emirates (UAE) has one of the world's fastest-growing economies, resulting in an increase in non-communicable diseases including cancer. Despite early detection and screening measures that seems to fall short of the target population's coverage goal, the number of detected cases along with deaths in the UAE has been increasing over time. In a single article, the NCBI, or National Center for Biotechnology Information, highlighted key features of a proposed UAE national cancer management plan. The concept is currently being developed and has not yet been formally adopted. For a thorough and effective management strategy, a reliable cancer registry, accurate data, and periodic monitoring and evaluation are all essential. In addition, the UAE's cancer management strategy is being established in accordance with EMRO and WHO recommendations, with specific goals and objectives in mind. The objectives are to combat cancer, reduce its occurrence, regulate mortality, and improve the outcomes and quality of life of cancer patients. Prevention, early detection, quick diagnosis, continuity of care, treatment facilitation, performance evaluation, and research are primary objectives.

The Brazil market dominated the LAMEA Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $999.8 Million by 2028. The Argentina market is estimated to grow at a CAGR of 9.4% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 8.5% during (2022 - 2028).

Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Analgesics Market is Predict to reach $42.6 Billion by 2028, at a CAGR of 6.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Non-opioids
• Opioids

By Route of Administration

• Oral
• Transdermal
• Intravenous
• Topical
• Rectal

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• AbbVie, Inc.
• Reckitt Benckiser Group PLC
• Abbott Laboratories
• Johnson & Johnson
• Bayer AG
• Endo International PLC
• GlaxoSmithKline PLC
• Pfizer, Inc.
• Sanofi S.A.
• Eli Lilly And Company

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Analgesics Market, by Type
1.4.2 LAMEA Analgesics Market, by Route of Administration
1.4.3 LAMEA Analgesics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Analgesics Market

Chapter 4. LAMEA Analgesics Market by Type
4.1 LAMEA Macro processing Market by Country
4.2 LAMEA Micro processing Market by Country

Chapter 5. LAMEA Analgesics Market by Route of Administration
5.1 LAMEA Oral Market by Country
5.2 LAMEA Transdermal Market by Country
5.3 LAMEA Intravenous Market by Country
5.4 LAMEA Topical Market by Country
5.5 LAMEA Rectal Market by Country

Chapter 6. LAMEA Analgesics Market by Country
6.1 Brazil Analgesics Market
6.1.1 Brazil Analgesics Market by Type
6.1.2 Brazil Analgesics Market by Route of Administration
6.2 Argentina Analgesics Market
6.2.1 Argentina Analgesics Market by Type
6.2.2 Argentina Analgesics Market by Route of Administration
6.3 UAE Analgesics Market
6.3.1 UAE Analgesics Market by Type
6.3.2 UAE Analgesics Market by Route of Administration
6.4 Saudi Arabia Analgesics Market
6.4.1 Saudi Arabia Analgesics Market by Type
6.4.2 Saudi Arabia Analgesics Market by Route of Administration
6.5 South Africa Analgesics Market
6.5.1 South Africa Analgesics Market by Type
6.5.2 South Africa Analgesics Market by Route of Administration
6.6 Nigeria Analgesics Market
6.6.1 Nigeria Analgesics Market by Type
6.6.2 Nigeria Analgesics Market by Route of Administration
6.7 Rest of LAMEA Analgesics Market
6.7.1 Rest of LAMEA Analgesics Market by Type
6.7.2 Rest of LAMEA Analgesics Market by Route of Administration

Chapter 7. Company Profiles
7.1 AbbVie, Inc. (Allergan PLC)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals and Trials:
7.2 Reckitt Benckiser Group PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.3.5.2 Approvals and Trials:
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 Bayer AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.6 Endo International PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 GlaxoSmithKline PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Geographical Expansions:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Sanofi S.A.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Eli Lilly And Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.2 Geographical Expansions:

TABLE 1 LAMEA Analgesics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Analgesics Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 4 LAMEA Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 5 LAMEA Macro processing Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Macro processing Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Micro processing Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Micro processing Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 10 LAMEA Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 11 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Transdermal Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Transdermal Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Intravenous Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Intravenous Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Rectal Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Rectal Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Analgesics Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Analgesics Market by Country, 2022 - 2028, USD Million
TABLE 23 Brazil Analgesics Market, 2018 - 2021, USD Million
TABLE 24 Brazil Analgesics Market, 2022 - 2028, USD Million
TABLE 25 Brazil Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 26 Brazil Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 27 Brazil Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 28 Brazil Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 29 Argentina Analgesics Market, 2018 - 2021, USD Million
TABLE 30 Argentina Analgesics Market, 2022 - 2028, USD Million
TABLE 31 Argentina Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 32 Argentina Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 33 Argentina Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 Argentina Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 UAE Analgesics Market, 2018 - 2021, USD Million
TABLE 36 UAE Analgesics Market, 2022 - 2028, USD Million
TABLE 37 UAE Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 38 UAE Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 39 UAE Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 40 UAE Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 41 Saudi Arabia Analgesics Market, 2018 - 2021, USD Million
TABLE 42 Saudi Arabia Analgesics Market, 2022 - 2028, USD Million
TABLE 43 Saudi Arabia Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 44 Saudi Arabia Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 45 Saudi Arabia Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 46 Saudi Arabia Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 47 South Africa Analgesics Market, 2018 - 2021, USD Million
TABLE 48 South Africa Analgesics Market, 2022 - 2028, USD Million
TABLE 49 South Africa Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 50 South Africa Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 51 South Africa Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 52 South Africa Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 53 Nigeria Analgesics Market, 2018 - 2021, USD Million
TABLE 54 Nigeria Analgesics Market, 2022 - 2028, USD Million
TABLE 55 Nigeria Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 56 Nigeria Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 57 Nigeria Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 Nigeria Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 Rest of LAMEA Analgesics Market, 2018 - 2021, USD Million
TABLE 60 Rest of LAMEA Analgesics Market, 2022 - 2028, USD Million
TABLE 61 Rest of LAMEA Analgesics Market by Type, 2018 - 2021, USD Million
TABLE 62 Rest of LAMEA Analgesics Market by Type, 2022 - 2028, USD Million
TABLE 63 Rest of LAMEA Analgesics Market by Route of Administration, 2018 - 2021, USD Million
TABLE 64 Rest of LAMEA Analgesics Market by Route of Administration, 2022 - 2028, USD Million
TABLE 65 Key information – AbbVie, Inc.
TABLE 66 Key information – Reckitt Benckiser Group PLC
TABLE 67 Key Information – Abbott Laboratories
TABLE 68 Key information – Johnson & Johnson
TABLE 69 Key Information – Bayer AG
TABLE 70 Key Information – Endo International PLC
TABLE 71 Key Information – GlaxoSmithKline PLC
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 Key Information – Sanofi S.A.
TABLE 74 Key Information – Eli Lilly And Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Abbott Laboratories
FIG 3 Recent strategies and developments: Eli Lilly And Company